Published in Oncotarget on April 19, 2016
Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer (2014) 40.30
The complete genome sequence of the gastric pathogen Helicobacter pylori. Nature (1997) 34.00
Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol (1996) 21.37
Genomic-sequence comparison of two unrelated isolates of the human gastric pathogen Helicobacter pylori. Nature (1999) 19.34
Helicobacter pylori infection. N Engl J Med (2002) 14.81
A review of human carcinogens--Part B: biological agents. Lancet Oncol (2009) 13.85
Properties of the summary receiver operating characteristic (SROC) curve for diagnostic test data. Stat Med (2002) 3.65
Carcinogenesis of Helicobacter pylori. Gastroenterology (2007) 3.63
Helicobacter pylori and gastric cancer: factors that modulate disease risk. Clin Microbiol Rev (2010) 3.41
Roles for motility in bacterial-host interactions. Mol Microbiol (1997) 3.16
Meta-analysis: can Helicobacter pylori eradication treatment reduce the risk for gastric cancer? Ann Intern Med (2009) 3.12
Association of Helicobacter pylori infection with gastric carcinoma: a meta-analysis. Am J Gastroenterol (1999) 3.01
Mechanisms of disease: Helicobacter pylori virulence factors. Nat Rev Gastroenterol Hepatol (2010) 2.56
Helicobacter infection and gastric neoplasia. J Pathol (2006) 2.54
Helicobacter pylori uses motility for initial colonization and to attain robust infection. Infect Immun (2002) 2.24
Summary receiver operating characteristic curve analysis techniques in the evaluation of diagnostic tests. Ann Thorac Surg (2005) 2.14
Functions of bacterial flagella. Crit Rev Microbiol (1996) 1.92
Helicobacter pylori in gastric cancer established by CagA immunoblot as a marker of past infection. Gastroenterology (2001) 1.87
Molecular cloning and characterization of the Helicobacter pylori fliD gene, an essential factor in flagellar structure and motility. J Bacteriol (1999) 1.40
Localization and stoichiometry of hook-associated proteins within Salmonella typhimurium flagella. J Bacteriol (1987) 1.33
Helicobacter pylori infection and gastric cancer risk: evaluation of 15 H. pylori proteins determined by novel multiplex serology. Cancer Res (2009) 1.33
H. pylori infection and gastric cancer: state of the art (review). Int J Oncol (2012) 1.32
Identification of immunodominant antigens from Helicobacter pylori and evaluation of their reactivities with sera from patients with different gastroduodenal pathologies. Infect Immun (2000) 1.23
The significance of virulence factors in Helicobacter pylori. J Dig Dis (2013) 1.16
Prospective study of Helicobacter pylori biomarkers for gastric cancer risk among Chinese men. Cancer Epidemiol Biomarkers Prev (2012) 1.13
Flagella and bacterial pathogenicity. J Basic Microbiol (2012) 1.13
Clinical significance of CA125 and CA72-4 in gastric cancer with peritoneal dissemination. Gastric Cancer (2011) 1.09
Comparative immunoproteomics of identification and characterization of virulence factors from Helicobacter pylori related to gastric cancer. Mol Cell Proteomics (2006) 1.08
Flagellar growth in a filament-less Salmonella fliD mutant supplemented with purified hook-associated protein 2. J Biochem (1993) 1.04
MicroRNAs as potential biomarkers for gastric cancer. World J Gastroenterol (2014) 1.02
Serum Helicobacter pylori CagA antibody as a biomarker for gastric cancer in east-Asian countries. Future Microbiol (2010) 1.02
Recent advances in the molecular diagnostics of gastric cancer. World J Gastroenterol (2015) 1.01
Atrophic gastritis: pathology and endoscopy in the reversibility assessment. Gut (2003) 0.98
A CagA-independent cluster of antigens related to the risk of noncardia gastric cancer: associations between Helicobacter pylori antibodies and gastric adenocarcinoma explored by multiplex serology. Int J Cancer (2013) 0.95
Expression of Helicobacter pylori CagA domains by library-based construct screening. FEBS J (2009) 0.93
Molecular screening of gastric cancer by proteome analysis. Eur J Gastroenterol Hepatol (2006) 0.93
Identification of candidate antigens for serologic detection of Helicobacter pylori-infected patients with gastric carcinoma. Int J Cancer (2004) 0.93
Combination of the serum carbohydrate antigen 19-9 and carcinoembryonic antigen is a simple and accurate predictor of mortality in pancreatic cancer patients. Surg Today (2013) 0.89
DNA methylation as a molecular biomarker in gastric cancer. Epigenomics (2015) 0.88
CagA and VacA are immunoblot markers of past Helicobacter pylori infection in atrophic body gastritis. Helicobacter (2007) 0.87
Serum Helicobacter pylori NapA antibody as a potential biomarker for gastric cancer. Sci Rep (2014) 0.85
Helicobacter pylori FliD protein is a highly sensitive and specific marker for serologic diagnosis of H. pylori infection. Int J Med Microbiol (2013) 0.81
Serum Helicobacter pylori CagA antibody may not be used as a tumor marker for diagnosing gastric cancer in east Asian countries. Tumour Biol (2014) 0.79
Serum antibody against Helicobacter pylori FlaA and risk of gastric cancer. Helicobacter (2013) 0.79
Construction of prokaryotic expression system of 2 148-bp fragment from cagA gene and detection of cagA gene, CagA protein in Helicobacter pylori isolates and its antibody in sera of patients. World J Gastroenterol (2004) 0.78
Cloning and expression of a recombinant CagA -gene fragment of Helicobacter pylori and its preliminary evaluation in serodiagnosis. Biomedica (2014) 0.76